scholarly journals Systemic endotheliitis in terms of novel coronavirus infection COVID-19: gender-related and perinatal risks

2022 ◽  
Vol 20 (4) ◽  
pp. 4-13
Author(s):  
I. Z. Chkhaidze ◽  
D. A. Lioznov ◽  
N . N. Petrishchev ◽  
D. A. Niauri
Keyword(s):  
Gender Differences ◽  
Vertical Transmission ◽  
Perinatal Outcomes ◽  
Professional Communities ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
The Impact ◽  
Perinatal Risks

The review considers some physiological features that reflect gender differences in the susceptibility to a novel coronavirus infection. Up-to-date information on the impact of COVID-19 on the course of pregnancy and perinatal outcomes is presented. The debatable issues of the possibility of vertical transmission of the SARS-CoV-2 virus are highlighted based on the analysis of available literature data and recommendations of international professional communities.

Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review

Coronaviruses ◽  
2020 ◽  
Vol 01 ◽  
Author(s):  
Saima Habeeb ◽  
Manju Chugani
Keyword(s):  
Pregnant Women ◽  
Vertical Transmission ◽  
Respiratory Infections ◽  
Age Groups ◽  
Well Being ◽  
Fetal Outcome ◽  
Global Public Health ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
The Impact

: The novel coronavirus infection (COVID‐19) is a global public health emergency.Since its outbreak in Wuhan, China in December 2019, the infection has spread at an alarming rate across the globe and humans have been locked down to their countries, cities and homes. As of now, the virus has affected over 20million people globally and has inflicted over 7 lac deaths. Nevertheless, the recovery rate is improving with each passing day and over 14 million people have recuperated so far. The statistics indicate that nobody is immune to the disease as the virus continues to spread among all age groups; newborns to the elders, and all compartmentsincluding pregnant women. However, pregnant women may be more susceptible to this infection as they are, in general, highly vulnerable to respiratory infections. There is no evidence for vertical transmission of the COVID-19 virus among pregnant women, but an increased prevalence of preterm deliveries. Besides this, the COVID-19 may alter immune response at the maternal-fetal interface and affect the well-being of mothers as well as infants. Unfortunately, there is limited evidence available in the open literature regarding coronavirus infection during pregnancy and it now appears that certain pregnant women have infected during the present 2019-nCoV pandemic. In this short communication, we study the impact of the COVID-19 infection on vertical transmission and fetal outcome among pregnant women.

scholarly journals A Review of Sars-Cov-2 Infection in Pregnancy: What We Know So Far

2020 ◽  
pp. 1-10
Author(s):  
Acevedo Gallegos Sandra ◽  
◽  
ArriagaLópez Alberto ◽  
Minjarez Corral Mariana ◽  
◽  
...  
Keyword(s):  
Vertical Transmission ◽  
Perinatal Outcomes ◽  
Diagnostic Methods ◽  
High Morbidity ◽  
Transmission Method ◽  
Coronavirus Infection ◽  
Recommended Guidelines ◽  
The Impact ◽  
In Pregnancy

Coronavirus infection (COVID-19) in pregnancy is highly relevant due to the impact on maternal and fetal health, it is caused by SARS-CoV-2, which has a high morbidity and mortality rate worldwide. It is important to evaluate pregnant patients who are identified as suspicious, to make an accurate and timely diagnosis, to implement correct follow-up and adequate therapeutic management to reduce associated complications and adverse perinatal outcomes. Objective: Execute a detailed and updated review of the causal agent, pathophysiology, diagnostic methods, treatment, maternal and fetal repercussions, via of delivery and whether there is evidence of vertical transmission. Method: A search of literature published in English and Spanish was carried out in databases such as PubMed / MEDLINE, MDconsult, HSTAT, Internet Grateful Med, using the keywords: Coronavirus, pregnancy, SARS-CoV-2, treatment, vertical transmission. From the information obtained, 88 articles were selected, which were classified and used as support to do this review. Results: Studies and available evidence, reviews, and recommended guidelines for the evaluation of patients with COVID-19 are discussed, mainly those that provide valuable data regarding the diagnosis, monitoring and management of this infection. Conclusion: Information is limited and much remains to be studied about vertical transmission and perinatal outcomes. There is no evidence to support that pregnancy increases the susceptibility to get COVID-19. More studies are necessary to know the behavior of the infection in pregnancy, for a better approach, diagnosis and treatment.

Association and treatment of diabetes in patients affected by Covid-19

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1198-1201
Author(s):  
Syed Yasir Afaque
Keyword(s):  
Diabetes Mellitus ◽  
Prognostic Value ◽  
Heart Diseases ◽  
The Novel ◽  
The World ◽  
Treatment Of Diabetes ◽  
Coronavirus Infection ◽  
Composite Outcomes ◽  
Novel Coronavirus ◽  
The Impact

In December 2019, a unique coronavirus infection, SARS-CoV-2, was first identified in the province of Wuhan in China. Since then, it spread rapidly all over the world and has been responsible for a large number of morbidity and mortality among humans. According to a latest study, Diabetes mellitus, heart diseases, Hypertension etc. are being considered important risk factors for the development of this infection and is also associated with unfavorable outcomes in these patients. There is little evidence concerning the trail back of these patients possibly because of a small number of participants and people who experienced primary composite outcomes (such as admission in the ICU, usage of machine-driven ventilation or even fatality of these patients). Until now, there are no academic findings that have proven independent prognostic value of diabetes on death in the novel Coronavirus patients. However, there are several conjectures linking Diabetes with the impact as well as progression of COVID-19 in these patients. The aim of this review is to acknowledge about the association amongst Diabetes and the novel Coronavirus and the result of the infection in such patients.

scholarly journals Vertical Transmission

2020 ◽  
Vol 41 (1) ◽  
pp. 2
Author(s):  
Dena Lyras
Keyword(s):  
Public Health ◽  
Infectious Disease ◽  
Vertical Transmission ◽  
Racial Groups ◽  
The Novel ◽  
Local Part ◽  
Rapid Dissemination ◽  
Novel Coronavirus ◽  
The Impact

As we begin 2020, Microbiology is dominating the news with the emergence and rapid dissemination of the novel coronavirus COVID-19. The impact of COVID-19 on public health, with significant financial, logistical and social repercussions, has quickly become apparent. As microbiologists we have an important role to play during this time because we can use our knowledge, expertise and experience to educate the community around us, and to reduce the panic that results from fear and misinformation. It is also critical that we ensure that racial groups are not stigmatised because of an infectious disease. A co-ordinated global effort is required to tackle this new infectious threat, and we are an important local part of this effort. It is also important to develop strategies that can be deployed when the next threat emerges, as it surely will.

scholarly journals COVID-19 vaccination of pregnant women: state-of-the-art

2021 ◽  
Vol 5 (11) ◽  
pp. 768-772
Author(s):  
A.A. Girina ◽  
◽  
A.L. Zaplatnikov ◽  
V.I. Svintsitskaya ◽  
S.D. Izhogina ◽  
...  
Keyword(s):  
Pregnant Women ◽  
State Of The Art ◽  
Severe Disease ◽  
Perinatal Outcomes ◽  
Professional Associations ◽  
Disease Course ◽  
Complete Control ◽  
Outcome Monitoring ◽  
Coronavirus Infection ◽  
Novel Coronavirus

Despite efforts made by the world community to battle the novel coronavirus infection, we are still unable to take complete control of virus spread. One of the causes of this issue is inadequate coverage of vaccination. Meanwhile, disease course in specific populations is associated with the risks of severe complications and lethal outcome. Infection of pregnant women is of particular concern. This paper addresses recent data on vaccination against the COVID-19 infection in pregnant women, including those with risk of severe disease course and unfavorable outcome. Monitoring the health of women infected with SARS-CoV-2 during gestation demonstrates unfavorable effects of the COVID-19 infection on the course and outcome of pregnancy. On the other hand, observational programs have demonstrated that vaccination has no effects on pregnancy course and perinatal outcomes. A view of the WHO and professional associations on the vaccination of pregnant women, particularly those from risk groups of severe COVID-19 course, is discussed. The importance of a personalized and balanced approach to COVID-19 vaccination of pregnant women involving the assessment of risks and benefits for the mother and child is emphasized. KEYWORDS: novel coronavirus infection, COVID-19, vaccination, immunization, pregnant women, risk group. FOR CITATION: Girina A.A., Zaplatnikov A.L., Svintsitskaya V.I., Izhogina S.D. COVID-19 vaccination of pregnant women: state-of-the-art. Russian Medical Inquiry. 2021;5(11):768–772 (in Russ.). DOI: 10.32364/2587-6821-2021-5-11-768-772.

scholarly journals Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children

2020 ◽  
Vol 39 (12) ◽  
pp. 2211-2223 ◽  
Author(s):  
Hongjun Miao ◽  
Han Li ◽  
Yinying Yao ◽  
Mingfu Wu ◽  
Chao Lu ◽  
...  
Keyword(s):  
Treatment Strategies ◽  
Diagnosis And Treatment ◽  
The Novel ◽  
Treatment Standards ◽  
Wuhan City ◽  
Health Committee ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
The Impact ◽  
Pneumonia Diagnosis

AbstractSince the outbreak of novel coronavirus infection pneumonia in Wuhan City, China, in late 2019, such cases have been gradually reported in other parts of China and abroad. Children have become susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) because of their immature immune function. As the outbreak has progressed, more cases of novel coronavirus infection/pneumonia in children have been reported. Compared with adults, the impact of SARS-CoV-2 infection in children is less severe, with a lower incidence and susceptibility in children, which results in fewer children being tested, thereby underestimating the actual number of infections. Therefore, strengthening the diagnosis of the disease is particularly important for children, and early and clear diagnosis can determine treatment strategies and reduce the harm caused by the disease to children. According to the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (trial version 7) issued by National Health Committee and the latest diagnosis and treatment strategies for novel coronavirus infection pneumonia in children, this review summarizes current strategies on diagnosis and treatment of SARS-CoV-2 infection in children.

IMPACT OF THE PANDEMIC ON INSURANCE IN THE TOURIST INDUSTRY

2020 ◽  
Vol 2 (10) ◽  
pp. 87-91
Author(s):  
Yu. E. KLISHINA ◽  
◽  
O. N. UGLITSKIKH ◽  
Keyword(s):  
Tourism Industry ◽  
The Novel ◽  
Tourist Industry ◽  
Travel Agents ◽  
Foreign Travel ◽  
Russian Economy ◽  
The World ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
The Impact

The article provides an overview of the impact of the coronavirus pandemic on the tourism industry. The contribution of the tourism industry to GDP and employment of the population is also considered. In particular, the impact of the pandemic on insurance in tourism was considered. The tourism industry is one of those sectors of the Russian economy that was among the first to be hit by the novel coronavirus infection. We are talking about a blow not only viral, medical – after all, the first outbreak in Russia was a consequence of the return of citizens from foreign travel, but also a financial blow – due to the spread of COVID-19 around the world, current tours had to be interrupted, and those planned at a later date – cancel or reschedule. In such conditions, tour operators, travel agents, carriers and other participants in the tourist services market suffered serious losses.

Hyperbaric oxygenation in the implementation of rehabilitation measures after COVID-19 pneumonia

2021 ◽  
pp. 7-11
Author(s):  
Tatyana Nikolaevna Kondratyeva ◽  
Natalya Alekseevna Kutalova
Keyword(s):  
Quality Of Life ◽  
Hyperbaric Oxygenation ◽  
The Body ◽  
The Novel ◽  
Complex Treatment ◽  
Coronavirus Infection ◽  
Rehabilitation Measures ◽  
Novel Coronavirus ◽  
The Impact

The aim of the study was to research the hyperbaric oxygenation effect on the condition of patients in the course of complex treatment aimed at rehabilitation after suffering from COVID-19 pneumonia. Results: the impact of hyperbaric oxygenation on the body of patients who have suffered from the novel coronavirus infection provides a positive dynamics and improves their quality of life. Conclusion: in the process of rehabilitating patients who have undergone the new coronavirus infection, it is necessary to use various physiotherapeutic measures, including hyperbaric oxygenation.

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period

2021 ◽  
Author(s):  
А.Г. Арутюнов ◽  
Г.П. Арутюнов ◽  
Е.И. Тарловская ◽  
Т.И. Батлук ◽  
Р.А. Башкинов ◽  
...  
Keyword(s):  
Calcium Channel ◽  
Beta Blocker ◽  
Calcium Channel Blockers ◽  
Large Scale ◽  
Channel Blockers ◽  
Blocker Therapy ◽  
Cardiovascular Patients ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
The Impact

С начала 2020 г. в мире распространилась инфекция, вызванная вирусом SARS-CoV-2, что в дальнейшем привело к пандемии COVID-19. Долгое время вопросы ведения пациентов с новой коронавирусной инфекцией в остром периоде рассматривались как первоочередные. По мере накопления клинического опыта и данных о возбудителе новой коронавирусной инфекции стало очевидно, что проблема последствий перенесенного COVID-19 и ведения пациентов на постгоспитальном этапе является такой же важной. В силу прямой и опосредованной кардиотоксичности вируса SARS-CoV-2 особую группу риска на всех этапах составляют пациенты с сердечно-сосудистыми заболеваниями. Поэтому одной из важных задач мирового медицинского сообщества стала разработка способов улучшения качества и прогноза жизни пациентов с сердечно-сосудистыми заболеваниями в постковидном периоде. В статье сделан обзор наиболее крупных исследований, включая данные регистра «Анализ динамики коморбидных заболеваний пациентов, перенесших инфицирование SARS-CoV-2 (AКТИВ SARS-CoV-2)», по вопросу медикаментозной терапии пациентов с сердечно-сосудистыми заболеваниями с акцентом на бета-адреноблокаторы и блокаторы кальциевых каналов. В представленных работах терапия бета-адреноблокаторами продемонстрировала благоприятное влияние на тяжесть течения новой коронавирусной инфекции у пациентов с сердечно-сосудистыми заболеваниями, снижение смертности на госпитальном и в отдаленном постгоспитальном периодах. Данные по применению блокаторов кальциевых каналов изучены в меньшей степени, но можно отметить, что данная группа препаратов является одной из самых часто назначаемых в терапии пациентов с сохранением стойких жалоб на повышение артериального давления на постгоспитальном этапе. Требуется дальнейшее изучение влияния отдельных классов антигипертензивных препаратов на прогноз пациентов с сердечно-сосудистыми заболеваниями и COVID-19. Early in 2020, the infection caused by SARS-CoV-2 emerged and caused the COVID-19 pandemic. For a long time, management of patients with the acute novel coronavirus infection was of primary importance. With accumulation of clinical information and data on the causative agents of novel coronavirus infection it became obvious that the COVID-19 consequences and post-hospital follow-up of patients are important as well. Due to the direct and mediated cardiac toxicity of SARS-CoV-2 virus, cardiovascular patients are at high risk at any stage of the disease. Therefore, one of the priorities for healthcare professionals is development of the ways to improve the quality and prognosis of life for cardiovascular patients in the post-COVID period. The article discusses large-scale studies including the data from the International Register «Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients» (AСTIV-SARS-CoV-2), as regards drug therapy of cardiovascular patients with a focus on beta-blockers and calcium-channel blockers. In mentioned publications, beta-blocker therapy demonstrated favourable impact on the novel coronavirus infection severity in cardiovascular patients, reduction in mortality rates during the hospital and post-hospital periods. Data on the use of calcium-channel blockers have been studied to a lesser extent; however, calcium-channel blockers are thought to be one of the most commonly prescribed groups in the therapy of patients with persistent complaints of high blood pressure at the post-hospital period. A study of the impact of some categories of antihypertensives on the outcome for cardiovascular patients with COVID-19 is warranted.

scholarly journals SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia

2021 ◽  
Vol 12 ◽  
Author(s):  
Ritu Mishra ◽  
Akhil C. Banerjea
Keyword(s):  
Gene Expression ◽  
Vaccine Development ◽  
Turnover Time ◽  
The Novel ◽  
Neurological Sequelae ◽  
Spike Gene ◽  
Human Microglia ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
The Impact

SARS-CoV-2, the novel coronavirus infection has consistently shown an association with neurological anomalies in patients, in addition to its usual respiratory distress syndrome. Multi-organ dysfunctions including neurological sequelae during COVID-19 persist even after declining viral load. We propose that SARS-CoV-2 gene product, Spike, is able to modify the host exosomal cargo, which gets transported to distant uninfected tissues and organs and can initiate a catastrophic immune cascade within Central Nervous System (CNS). SARS-CoV-2 Spike transfected cells release a significant amount of exosomes loaded with microRNAs such as miR-148a and miR-590. microRNAs gets internalized by human microglia and suppress target gene expression of USP33 (Ubiquitin Specific peptidase 33) and downstream IRF9 levels. Cellular levels of USP33 regulate the turnover time of IRF9 via deubiquitylation. Our results also demonstrate that absorption of modified exosomes effectively regulate the major pro-inflammatory gene expression profile of TNFα, NF-κB and IFN-β. These results uncover a bystander pathway of SARS-CoV-2 mediated CNS damage through hyperactivation of human microglia. Our results also attempt to explain the extra-pulmonary dysfunctions observed in COVID-19 cases when active replication of virus is not supported. Since Spike gene and mRNAs have been extensively picked up for vaccine development; the knowledge of host immune response against spike gene and protein holds a great significance. Our study therefore provides novel and relevant insights regarding the impact of Spike gene on shuttling of host microRNAs via exosomes to trigger the neuroinflammation.

Sign in / Sign up

Export Citation Format

Share Document